Aoife Brennan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Aoife Brennan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Aoife Brennan. Aoife Brennan is Director in FIBROGEN INC ($FGEN) and Director in Ra Pharmaceuticals, Inc. ($RARX) and Chief Medical Officer in SYNLOGIC, INC. ($MIRN) and Interim President and CEO in SYNLOGIC, INC. ($SYBX) and President and CEO in SYNLOGIC, INC. ($SYBX) and See Remarks in SYNLOGIC, INC. ($SYBX).
Latest Insider Trading Transactions of Aoife Brennan
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FGEN, RARX, SYBX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 3.50 | 285,000 | 997,500 | 285,000 | |
Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 3.50 | 285,000 | 997,500 | 285,000 | |
Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 71,250 | 0 | 177,317 | 106.1 K to 177.3 K (+67.17 %) |
Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 71,250 | 0 | 177,317 | 106.1 K to 177.3 K (+67.17 %) |
Aug 07 2020 | FGEN | FIBROGEN INC | Brennan Aoife | Director | Option Exercise | A | 42.65 | 10,400 | 443,560 | 10,400 | |
Aug 07 2020 | FGEN | FIBROGEN INC | Brennan Aoife | Director | Option Exercise | A | 42.65 | 6,496 | 277,054 | 6,496 | |
Aug 07 2020 | FGEN | FIBROGEN INC | Brennan Aoife | Director | Grant | A | 0.00 | 3,914 | 0 | 3,914 | 0 to 3.9 K |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Brennan Aoife | Director | Option Exercise | D | 16.36 | 25,000 | 409,000 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Brennan Aoife | Director | Option Exercise | D | 19.88 | 15,000 | 298,200 | 0 | |
Mar 12 2020 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 1.70 | 185,300 | 315,010 | 185,300 | |
Mar 12 2020 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 46,300 | 0 | 106,067 | 59.8 K to 106.1 K (+77.47 %) |
Sep 25 2019 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 8,000 | 0 | 59,767 | 51.8 K to 59.8 K (+15.45 %) |
Jun 13 2019 | RARX | Ra Pharmaceuticals ... | Brennan Aoife | Director | Option Exercise | A | 19.88 | 15,000 | 298,200 | 15,000 | |
Mar 06 2019 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 8.59 | 185,000 | 1,589,150 | 185,000 | |
Nov 01 2018 | SYBX | SYNLOGIC, INC. | Brennan Aoife | President and CEO | Option Exercise | A | 7.91 | 150,000 | 1,186,500 | 150,000 | |
Sep 25 2018 | RARX | Ra Pharmaceuticals ... | Brennan Aoife | Director | Option Exercise | A | 16.36 | 25,000 | 409,000 | 25,000 | |
Jun 06 2018 | SYBX | SYNLOGIC, INC. | Brennan Aoife | Interim President a ... | Option Exercise | A | 9.55 | 54,000 | 515,700 | 54,000 | |
Mar 15 2018 | MIRN | SYNLOGIC, INC. | Brennan Aoife | Chief Medical Offic ... | Option Exercise | A | 9.95 | 56,000 | 557,200 | 56,000 |
Page: 1